ASCO

With three more ASCO meetings this year, there are still plenty of opportunities to connect with peers, discover groundbreaking cancer research, & gain clinical insights. Don't miss out on our meetings—the ultimate Place to Be. Where will we see you this year?

Though the potential therapeutic effects of cannabis are relevant for patients with cancer, clinicians must weigh the symptomatic benefits against emerging cardiopulmonary risks. @timpawlik, @ZRashidMD & Dr. Erin Stevens discuss for #ASCODailyNews: bit.ly/48BxfTt

Thank you @SenatorTimScott and @MarkWarner for introducing the #ASCOAdvocacy endorsed Clinical Trials Modernization Act in the Senate! This legislation is essential to expand access to clinical trials for all patients.

Get hyped for #ASCO26 🚀with a look back at last year’s meeting as experienced by the @OncBrothers! Join us this year in person or online: bit.ly/4cHx4Y6

Last Call for Funding! 🚨 @LobularBCA is collaborating with Conquer Cancer’s EveryGrant to implement Clinical Research Grant program to fund independent physician investigators/research scientists who are committed to conducting preclinical, translational, or clinical ILC research. Apply soon: bit.ly/3OTflEW

New Funding Opportunity! Early-career oncologists: Apply for the @conquercancerFD YIA in Pediatric Brain Tumors. This mentored award supports your transition from fellowship to faculty with a $50k grant. Apply by July 15, 2026: bit.ly/4ueKOk9 #CancerResearch

Last week we attended the #ASCOAdovcacySummit with @drteplinsky! See what it's like to be on Capitol Hill with a first-time Summit attendee! You can still take action online: bit.ly/4n08WVj

ASCO Annual Meeting 2026 in Chicago May 29th-June 2nd. Abstracts just released!! Abstract LBA100: NHS- Galleri: Primary results from a randomized controlled trial to assess the clinical utility of a multi-cancer early detection (MCED)test in population screening. @ASCO @ASCOPres

The ASCO Annual Meeting 2026 in Chicago is almost here, and the abstracts are finally out! LBA6007: Ultra-low-dose immunotherapy plus oral metronomic chemotherapy versus paclitaxel-carboplatin in recurrent or metastatic head and neck squamous cell carcinoma @ASCO @ASCOPres

American Society of Clinical Oncology (ASCO) Annual Meeting 2026 in Chicago May 29th-June 2nd. Abstracts just released!! Abstract 1508 on WHO essential cancer list in LMIC. @ASCO @ASCOPres

🤝Only one month left until #ASCO26! What are you looking forward to the most at this year’s meeting?

Medical education is undergoing a fundamental transformation. For #ASCODailyNews, @HundalJasmin and @drteplinsky discuss how digital media, gamified learning strategies & #AI are changing how knowledge is disseminated and acquired in oncology training: bit.ly/3QwBxoW

Join us in congratulating the following members on earning the Fellows of ASCO (FASCO) distinction! We are grateful for their extraordinary volunteer service, dedication, and commitment to ASCO. Learn more about FASCO distinction: bit.ly/3OLrVWK

🎉Thank you to our dedicated volunteers! Together we connected with lawmakers & advocated for cancer care and research priorities during the 2026 #ASCOAdvocacySummit and Week of Action. Learn more: bit.ly/4vJe1oZ

Congrats to the 2026-2027 ASCO Leadership Development Program (LDP) & LDP: Education Scholars participants! 🎉These members will hone leadership skills while learning about program-specific strategies. Want to join next year? Apply this summer! ➡️ bit.ly/4c6SFKo

We’re asking lawmakers to strengthen access to cancer care by permanently extending Medicare telehealth flexibilities. Urge your Members of Congress to take action: bit.ly/4cHCceH #ASCOAdvocacySummit

Urge your Members of Congress to #FixPriorAuth & improve patient care by passing legislation to streamline the process, hold health plans accountable, & improve transparency around denials: bit.ly/48WqBXV #ASCOAdvocacySummit

Check out the latest #TAPUR Study paper in #JCOPO: Temsirolimus in Patients With Solid Tumors With PIK3CA Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study. Read the full article: bit.ly/4cVvaUU

Conquer Cancer is thrilled to announce our support of 141 recipients of 2026 ASCO Annual Meeting Merit Awards and 5 Special Merit Awards. These awards support students and trainees with outstanding research for presentation at the 2026 ASCO Meeting. Special Merit Awards are presented to top-ranking abstracts. See the list of recipients: bit.ly/4sNlFfa @ASCO #ASCO26 #ResearchConquersCancer #ConquerCancer

📱For our #ASCO26 coverage on social, which topics or session types are you most interested in having covered?

During #ASCOAdvocacySummit we asked lawmakers to prioritize robust funding for @NIH, @theNCI, & @ARPA_H in fiscal year 2027 to support research, maintain the workforce, & drive breakthroughs that improve treatment options. Add your voice ➡️ bit.ly/4tleU5g